MedTrace Logo

Conditioned Placebo Effects and Treatment of Hypertension

NCT00269269 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

To compare the unconditioned and conditioned effects of placebo capsules in the treatment of patients with borderline hypertension (BH).

Conditions

Interventions

DRUG

antihypertensive drug

BEHAVIORAL

placebo

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Thomas Pickering · Columbia University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2007-07-31
Completion
2007-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00269269 on ClinicalTrials.gov